Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder. (Q54588466)

1 June 2018

title

Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder. (English)

1 reference

1 June 2018

0 references

Wu Yin

1

1 reference

1 June 2018

Ni Chen

2

1 reference

1 June 2018

Yutao Zhang

3

1 reference

1 June 2018

Hao Zeng

4

1 reference

1 June 2018

Xueqin Chen

5

1 reference

1 June 2018

Yongtao He

6

1 reference

1 June 2018

Xiaojie Wang

7

1 reference

1 June 2018

Qiao Zhou

8

1 reference

1 June 2018

publication date

4 August 2006

1 reference

1 June 2018

published in

Modern Pathology

1 reference

1 June 2018

volume

19

1 reference

1 June 2018

issue

11

1 reference

1 June 2018

page(s)

1487-1497

1 reference

1 June 2018

cites work

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Proliferation in human bladder carcinoma measured by Ki-67 antibody labelling: its potential clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Relationship of p53 and bcl-2 to prognosis in muscle-invasive transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Expression of the apoptosis suppressing bcl-2 protein in transitional cell bladder tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug-resistant TCC in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Caspase activation - stepping on the gas or releasing the brakes? Lessons from humans and flies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Caspase activation, inhibition, and reactivation: a mechanistic view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Molecular mechanisms of caspase regulation during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

IAP proteins: blocking the road to death's door

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Systematic in vitro evaluation of survivin directed antisense oligodeoxynucleotides in bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Overexpression of caspase-3 in hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Control of apoptosis and mitotic spindle checkpoint by survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Nuclear survivin as a biomarker for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Prognostic importance of survivin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Nuclear or cytoplasmic expression of survivin: what is the significance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

7 January 2021

Bcl-2/bax mRNA expression ratio as prognostic factor in low-grade urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

7 January 2021

Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa/T1) bladder cancer: a prospective comparative study. The Finnbladder Group

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

7 January 2021

Prognostic value of Ki-67 antigen and p53 protein in urinary bladder cancer: immunohistochemical analysis of radical cystectomy specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

7 January 2021

Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

7 January 2021

Prognostic value of the proliferative index determined by Ki-67 immunostaining in superficial bladder tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

7 January 2021

The role of bcl-2, p53, and ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

7 January 2021

Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

7 January 2021

Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

7 January 2021

Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

7 January 2021

p53 and ki67 expression as prognostic factors for cancer-related survival in stage T1 transitional cell bladder carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

7 January 2021

Urine detection of survivin and diagnosis of bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

7 January 2021

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800675

1 reference

7 January 2021

10.1038/MODPATHOL.3800675

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rnegowwkfbaf7bfdywbczxzkua

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_rnegowwkfbaf7bfdywbczxzkua

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rnegowwkfbaf7bfdywbczxzkua

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/rnegowwkfbaf7bfdywbczxzkua

1 reference

30 July 2022